A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Clinical trial NCT07413666 · RECRUITING

Trial details

NCT number: NCT07413666
Sponsor: Centessa Pharmaceuticals (UK) Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male and Female Volunteers

Start date: 2026-02-25
Primary completion: 2027-06-30
Enrollment: 212

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.